Predicate devices are a core element of 510(k) submissions, but the need to perform direct comparisons to a specific predicate on the market sometimes adds unnecessary challenges to proving a device is safe. US FDA is hoping to help solve that issue by reworking its "abbreviated" 510(k) program to offer new options.
Under a draft guidance posted April 11, the agency says it could allow certain medical devices to market without the need to compare them with a similar and already...